Caplin Point Laboratories Market Cap

Caplin Point Laboratories has a market cap or net worth of 126.80 billion as of March 9, 2026. Its market cap has decreased by -12.92% in one year.

Market Cap

126.80B

Enterprise Value

117.82B

Revenue

20.92B

Ranking

n/a

PE Ratio

20.72

Stock Price

1,668.10

Market Cap Chart

Since February 26, 2002, Caplin Point Laboratories's market cap has increased from 5.60M to 126.80B, an increase of 2,264,502.79%. That is a compound annual growth rate of 51.74%.

Market Cap History

Date	Market Cap	% Change
Mar 9, 2026	126.80B	-9.40%
Dec 31, 2025	139.95B	-26.39%
Dec 31, 2024	190.12B	84.60%
Dec 29, 2023	102.99B	90.47%
Dec 30, 2022	54.07B	-16.82%
Dec 31, 2021	65.01B	69.50%
Dec 31, 2020	Pro	Pro
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Rubicon Research	126.17B
Jubilant Pharmova	129.48B
Granules India	142.93B
CORONA Remedies	96.72B
Viyash Scientific	88.60B
Sanofi India	87.18B
Procter & Gamble Health	81.02B
AstraZeneca Pharma India	218.50B

Market Cap Rankings